Header image

Session M: Hepatitis prevention, treatment, and care in prisons

Tracks
Track 1
Thursday, September 12, 2019
2:00 PM - 3:00 PM
Montreal A & B, Level 11

Speaker

Dr. Justin Chan
Director of Viral Hepatitis Services
Correctional Health Services, NYC Health + Hospitals

THE HEPATITIS C VIRUS (HCV) CASCADE OF CARE IN THE NEW YORK CITY (NYC) JAIL SYSTEM

2:00 PM - 2:15 PM

Abstract

Speaker Presentation

Video Recording

Biography

Justin Chan serves as Director of Viral Hepatitis Services for NYC Health + Hospitals / Correctional Health Services, working to expand HCV care in NYC jails. He received his MD from Icahn School of Medicine at Mount Sinai, and his MPH from the Harvard T.H. Chan School of Public Health.
Dr Lise Lafferty
Research Fellow
UNSW Sydney

INJECTING CULTURE FOLLOWING PRISON-WIDE HEPATITIS C TREATMENT SCALE-UP: NEGOTIATING RISK AFTER CUR

2:15 PM - 2:30 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr Lafferty is a research fellow at the Centre for Social Research in Health, UNSW Sydney. Her research focuses on the social and behavioural components underpinning hepatitis C risk, prevention, transmission, testing, treatment, and reinfection in the prison setting.
Miss Sophia Schroeder
PhD Candidate
Burnet Institute

‘SET UP TO FAIL’: THE POST-RELEASE EXPERIENCE OF PRISONERS WITH A HISTORY OF INJECTION DRUG USE

2:30 PM - 2:45 PM

Abstract

Speaker Presentation

Video Recording

Biography

Sophia is a PhD candidate and works at Burnet Institute across multiple projects. She has a particular interest in qualitative research seeking to understand and address barriers to wellbeing among marginalised and key populations; including people who use drugs, prisoners, gay and bisexual men, and young people.
Dr. Matthew Akiyama
Assistant Professor Of Medicine
Montefiore Medical Center / Albert Einstein College Of Medicine

PERCEIVED BARRIERS TO AND FACILITATORS OF HCV TREATMENT UPTAKE IN JAIL AND LINKAGE TO HCV CARE AFTER INCARCERATION: A QUALITATIVE STUDY

2:45 PM - 2:50 PM

Abstract

Speaker Presentation

Video Recording

Biography

Matthew Akiyama is a physician-investigator whose research focuses on HCV among socioeconomically marginalized populations and the criminal justice system. Dr. Akiyama is the recipient of NIH and institutional funding to develop and test innovative strategies to improve the HCV care cascade among individuals with justice-involvement and people who inject drugs.
Mr Arnaud Godin
Student
McGill University

ENHANCING LINKAGE TO HEPATITIS C CARE UPON RELEASE FROM CANADIAN PROVINCIAL PRISONS: THE POPULATION-LEVEL IMPACT ON HEPATITIS C TRANSMISSION AMONG PEOPLE WHO INJECT DRUGS IN MONTRÉAL

2:50 PM - 2:55 PM

Abstract

Biography

Trained in economics, I currently work on the modelling of hepatitis C among priority populations (people who inject drugs, people in prison) and the impact of prison-based interventions in a microelimination framework.
Dr. Nadine Kronfli
Assistant Professor, Clinician-Investigator
McGill University

Disparities in Hepatitis C virus (HCV) care across Quebec’s provincial prisons: Implications for HCV micro-elimination

2:55 PM - 3:00 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr. Nadine Kronfli is an assistant professor in the Department of Medicine, Division of Infectious Diseases at McGill University and a Junior Scientist at the Research Institute of the McGill University Health Centre. Her research focuses on improving engagement in hepatitis C care for people in prison.

Chair

Lisa Barrett
Clinician Scientist
Dalhousie University

Andrew Lloyd
Program Head
The Kirby Institute

loading